What is Fensafe 222mg (FENBENDAZOLE)?
Veterinary anthelmintic gaining attention in cancer research following anecdotal reports and in vitro/animal studies showing anti-tumor activity. Not approved for human cancer treatment.
How it Works
Benzimidazole inhibiting tubulin polymerization. In cancer research: inhibits glucose uptake (GLUT transporters), destabilizes microtubules in tumor cells, activates p53, interferes with cancer energy metabolism.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | FENBENDAZOLE |
| Dose per Tablet | 222MG |
| Pack Size | 10×10 (100 tablets) |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Generally well tolerated. Nausea, abdominal discomfort, elevated liver enzymes — monitor LFTs with extended use.
Safety Warnings
⚠️ NOT approved for human cancer treatment — off-label and investigational. Monitor liver function. No established human dosing protocol. Do not substitute for proven cancer treatments.
🌏 International shipping: 7–14 days
